Read the latest issue of CHR and learn how the AAN is fighting on behalf of neurologists and neurology
The registry will collect key data to improve health care. Learn what it means for your practice.
Read the latest news and see how the AAN is raising public awareness of neurology and neurologists.
Class II evidence that for patients with RRMS switching from natalizumab to fingolimod, shorter natalizumab WO periods are associated with less MRI disease activity than are longer WO periods.
Genetic analysis for a shared biological basis between migraine and coronary artery disease
Predictive value of early brain atrophy on response in patients treated with interferon β
Feske, Steven K., MD; Singhal, Aneesh B., MD
Bove, Riley M., MD; Klein, Joshua P., MD, PhD
Amato, Anthony A., MD, FAAN; Greenberg, Steven A., MD
New Study Suggests Brain Is Connected to the Lymphatic System: What the Discovery Could Mean for Neurology
News from the MDS International Congress: Inhaled Levodopa Quickly Abolishes 'Off Time' Symptoms for Parkinson's Patients
A Leader Takes on Brain Disease: Two personal tragedies spur former Vice President Walter F. Mondale’s support for aggressive brain research.
Readers Like Me: We asked 10 subscribers who have been with Neurology Now for 10 years to share their stories. Here’s what they told us.
Defeating a Rare Disorder: After two of their children died from a mysterious illness, Laurian and John Scott pushed to find the gene that caused it—and brought new hope to dozens of families.
Gordon, Debra MS